Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriele Gugliotta

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Annals of Hematology|March 28, 2015
A review of the European LeukemiaNet recommendations for the management of CMLMichele Baccarani, Fausto Castagnetti, Gabriele Gugliotta, et al.
Nature Reviews. Clinical Oncology|November 3, 2016
Tyrosine kinase inhibitors in chronic myeloid leukaemia: which, when, for whom?Gianantonio Rosti, Fausto Castagnetti, Gabriele Gugliotta, et al.
Cancer Treatment Reviews|August 16, 2011
Physician's guide to the clinical management of adverse events on nilotinib therapy for the treatment of CMLGianantonio Rosti, Fausto Castagnetti, Gabriele Gugliotta, et al.
Aging|December 29, 2011
Imatinib in chronic myeloid leukemia elderly patientsGabriele Gugliotta, Fausto Castagnetti, Francesca Palandri, et al.
Expert Review of Hematology|March 27, 2014
Definition and treatment of resistance to tyrosine kinase inhibitors in chronic myeloid leukemiaMichele Baccarani, Fausto Castagnetti, Gabriele Gugliotta, et al.
Hemasphere|March 21, 2022
Current treatment approaches in CMLFausto Castagnetti, Gabriele Gugliotta, Simona Soverini, et al.
Italian Journal of Dermatology and Venereology|January 30, 2024
Psoriasis: a new adverse event of ibrutinibLuca Rapparini, Alice Massi, Carlotta Baraldi, et al.
Best Practice & Research. Clinical Haematology|December 5, 2009
Response definitions and European Leukemianet Management recommendationsMichele Baccarani, Fausto Castagnetti, Gabriele Gugliotta, et al.
Critical Reviews in Oncology/Hematology|May 14, 2011
Second-generation BCR-ABL inhibitors for frontline treatment of chronic myeloid leukemia in chronic phaseGianantonio Rosti, Fausto Castagnetti, Gabriele Gugliotta, et al.
Mediterranean Journal of Hematology and Infectious Diseases|January 24, 2014
Treatment recommendations for chronic myeloid leukemiaMichele Baccarani, Fausto Castagnetti, Gabriele Gugliotta, et al.
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Annals of Hematology|March 28, 2015
A review of the European LeukemiaNet recommendations for the management of CMLMichele Baccarani, Fausto Castagnetti, Gabriele Gugliotta, et al.
Nature Reviews. Clinical Oncology|November 3, 2016
Tyrosine kinase inhibitors in chronic myeloid leukaemia: which, when, for whom?Gianantonio Rosti, Fausto Castagnetti, Gabriele Gugliotta, et al.
Cancer Treatment Reviews|August 16, 2011
Physician's guide to the clinical management of adverse events on nilotinib therapy for the treatment of CMLGianantonio Rosti, Fausto Castagnetti, Gabriele Gugliotta, et al.
Aging|December 29, 2011
Imatinib in chronic myeloid leukemia elderly patientsGabriele Gugliotta, Fausto Castagnetti, Francesca Palandri, et al.
Expert Review of Hematology|March 27, 2014
Definition and treatment of resistance to tyrosine kinase inhibitors in chronic myeloid leukemiaMichele Baccarani, Fausto Castagnetti, Gabriele Gugliotta, et al.
Hemasphere|March 21, 2022
Current treatment approaches in CMLFausto Castagnetti, Gabriele Gugliotta, Simona Soverini, et al.
Italian Journal of Dermatology and Venereology|January 30, 2024
Psoriasis: a new adverse event of ibrutinibLuca Rapparini, Alice Massi, Carlotta Baraldi, et al.
Best Practice & Research. Clinical Haematology|December 5, 2009
Response definitions and European Leukemianet Management recommendationsMichele Baccarani, Fausto Castagnetti, Gabriele Gugliotta, et al.
Critical Reviews in Oncology/Hematology|May 14, 2011
Second-generation BCR-ABL inhibitors for frontline treatment of chronic myeloid leukemia in chronic phaseGianantonio Rosti, Fausto Castagnetti, Gabriele Gugliotta, et al.
Mediterranean Journal of Hematology and Infectious Diseases|January 24, 2014
Treatment recommendations for chronic myeloid leukemiaMichele Baccarani, Fausto Castagnetti, Gabriele Gugliotta, et al.
Pageof 9